What they're saying
“With her years of experience and success with medical device start-up companies, Jan Garfinkle has a deep understanding of what it takes. Jan’s knowledge, together with her thoughtful and disciplined approach, helps us in developing and implementing practical and effective solutions."
"Partnering with Paul McCreadie and the Arboretum team has been a great experience. As our Chairman, Paul’s strategic direction and insight has had an invaluable impact on our growth and success. In addition, Arboretum’s extensive network is an incredible asset I can leverage as we continue to execute."
“Leading a company from its earliest days to realizing a liquidity event is never easy. In order to succeed, you need team members like Arboretum Ventures that redefine ‘value-added investor’. Arboretum never loses focus when things are going well and never disappears when there are bumps in the road.”
“Tim Petersen provided Accuri with the type of Board of Directors leadership that is critical for any company to grow and thrive. Instead of getting bogged down in minutia that could have steered us off course, Tim provided us with honest strategic guidance that supported management in achieving our vision and objectives for Accuri.”
Arboretum in the news
Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Founded in 2002, the firm manages $235 million in capital and has invested in more than 30 companies, five of which have exited with an aggregate valuation of approximately $1 billion. These successes have positioned Arboretum Ventures’ first two funds as top-quartile performers according to recognized industry benchmarks.*
Headquartered in Ann Arbor, Arboretum invests throughout the United States, but with a preference for Midwest opportunities. Our team targets capital efficient companies that can meaningfully reduce healthcare costs in our areas of expertise: devices, diagnostics, services, and IT. We are actively seeking new investments for Arboretum Ventures III, a $138 million fund raised in 2011.
*Industry benchmarks include Net IRR and Distributions to Paid-in Capital, as reported by Cambridge Associates.